Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7S3M

MERS-CoV S stem helix peptide bound to Fab22

7S3M の概要
エントリーDOI10.2210/pdb7s3m/pdb
分子名称Spike glycoprotein, Fab22 Heavy Chain, Fab22 Light Chain, ... (4 entities in total)
機能のキーワードspike, fusion, antibody, viral protein-immune system complex, viral protein/immune system
由来する生物種Mus musculus (Mouse)
詳細
タンパク質・核酸の鎖数3
化学式量合計49783.60
構造登録者
Goldsmith, J.A.,McLellan, J.S. (登録日: 2021-09-07, 公開日: 2021-10-27, 最終更新日: 2024-10-30)
主引用文献Hsieh, C.L.,Werner, A.P.,Leist, S.R.,Stevens, L.J.,Falconer, E.,Goldsmith, J.A.,Chou, C.W.,Abiona, O.M.,West, A.,Westendorf, K.,Muthuraman, K.,Fritch, E.J.,Dinnon 3rd, K.H.,Schafer, A.,Denison, M.R.,Chappell, J.D.,Baric, R.S.,Graham, B.S.,Corbett, K.S.,McLellan, J.S.
Stabilized coronavirus spike stem elicits a broadly protective antibody.
Cell Rep, 37:109929-109929, 2021
Cited by
PubMed Abstract: Current coronavirus (CoV) vaccines primarily target immunodominant epitopes in the S1 subunit, which are poorly conserved and susceptible to escape mutations, thus threatening vaccine efficacy. Here, we use structure-guided protein engineering to remove the S1 subunit from the Middle East respiratory syndrome (MERS)-CoV spike (S) glycoprotein and develop stabilized stem (SS) antigens. Vaccination with MERS SS elicits cross-reactive β-CoV antibody responses and protects mice against lethal MERS-CoV challenge. High-throughput screening of antibody-secreting cells from MERS SS-immunized mice led to the discovery of a panel of cross-reactive monoclonal antibodies. Among them, antibody IgG22 binds with high affinity to both MERS-CoV and severe acute respiratory syndrome (SARS)-CoV-2 S proteins, and a combination of electron microscopy and crystal structures localizes the epitope to a conserved coiled-coil region in the S2 subunit. Passive transfer of IgG22 protects mice against both MERS-CoV and SARS-CoV-2 challenge. Collectively, these results provide a proof of principle for cross-reactive CoV antibodies and inform the development of pan-CoV vaccines and therapeutic antibodies.
PubMed: 34710354
DOI: 10.1016/j.celrep.2021.109929
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.4 Å)
構造検証レポート
Validation report summary of 7s3m
検証レポート(詳細版)ダウンロードをダウンロード

252091

件を2026-04-15に公開中

PDB statisticsPDBj update infoContact PDBjnumon